Timing Pharmaceutical Co. Ltd.
TTPEX:665920.40
TWD
+0.20
(+0.99%)
ISIN
TW0006659006
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Semi-annual Revenue
FRC
•
in mil. unless spec.Semi-annual Earnings Per Share
FRC
•
in mil. unless spec.Semi-annual Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Full Time Employees
- 441
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Taiwan
- Similar Companies
- Business
- Timing Pharmaceutical Co. Ltd. is a Taiwan-based pharmaceutical enterprise engaged in the research, development, manufacturing, and commercial distribution of prescription drugs, active pharmaceutical ingredients, and healthcare formulations. Founded in 2012 and headquartered in New Taipei City, Taiwan, the company operates through distinct business segments comprising Prescription Pharmaceuticals, Specialty Formulations, Over-the-Counter Healthcare Products, and Contract Development and Manufacturing Organization (CDMO) services. The company offers a comprehensive portfolio of pharmaceutical and healthcare products, including oral solid dosage formulations, tablets, and capsules for chronic disease management; cardiovascular agents, antihypertensives, and lipid-regulating therapeutics; central nervous system medications, analgesics, and anti-inflammatory compounds; gastrointestinal and metabolic disease treatments; antimicrobial and respiratory formulations; active pharmaceutical ingredients (APIs) and advanced chemical intermediates; over-the-counter dietary supplements, functional nutritional products, and botanical health remedies; as well as customized contract manufacturing, formulation development, quality assurance testing, and regulatory filing support services for institutional healthcare partners. Timing Pharmaceutical Co. Ltd. supplies its products to medical centers, regional hospitals, community clinics, and retail pharmacy chains across Taiwan, while actively maintaining export channels and distribution networks across the Asia-Pacific region. In recent corporate developments, Timing Pharmaceutical Co. Ltd. has executed several strategic initiatives to broaden its market footprint and technological capabilities. The company entered into strategic co-development and licensing agreements with regional biopharmaceutical partners to co-develop extended-release specialty formulations and expand international distribution pathways. Operationally, the company upgraded and expanded its PIC/S GMP-compliant manufacturing facilities to scale production capacities for high-potency oral dosage forms and sterile injectable lines. Furthermore, Timing Pharmaceutical Co. Ltd. recently launched a new series of targeted generic cardiovascular and metabolic medications, expanded its specialized CDMO services to support external clinical pipeline manufacturing, and strengthened its research and development pipeline focused on novel drug delivery systems.